Les héparines = HeparinsLa Revue du praticien (Paris). 1988, Vol 38, Num 15, pp 917-964, issn 0035-2640, 44 p.Article

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIRAGAZZI, M; FERRO, D. R; PERLY, B et al.Carbohydrate research. 1987, Vol 165, Num 1, pp C1-C5, issn 0008-6215Article

The heparin story. In search of the early history of heparinBOTTIGER, L. E.Acta medica Scandinavica. 1987, Vol 222, Num 3, pp 195-200, issn 0001-6101Article

Thrombocytopenia associated with low-molecular-weight heparinLECOMPTE, T; SHAO KAI LUO; BERTRAND, J. C et al.Lancet (British edition). 1991, Vol 338, Num 8776, issn 0140-6736, p. 1217Article

Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assayKATRANCIOGLU, Nurkay; KARAHAN, Oguz; TURHAN KILIC, Ahmet et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 3, pp 218-221, issn 0957-5235, 4 p.Article

Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparinDE CANDIA, E; DE CRISTOFARO, R; LANDOLFI, R et al.Circulation (New York, N.Y.). 1999, Vol 99, Num 25, pp 3308-3314, issn 0009-7322Article

Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analoguesJESKE, W; JAWED FAREED.Seminars in thrombosis and hemostasis. 1993, Vol 19, pp 241-247, issn 0094-6176, SUP1Article

Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulationZMUDA, K; NEOFOTISTOS, D; TS'AO, C.-H et al.American journal of clinical pathology. 2000, Vol 113, Num 5, pp 725-731, issn 0002-9173Article

Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitorALTMAN, R; SCAZZIOTA, A; ROUVIER, J et al.Haemostasis. 1998, Vol 28, Num 5, pp 229-235, issn 0301-0147Article

Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombinKIM, Y. S; LINHARDT, R. J.Thrombosis research. 1989, Vol 53, Num 1, pp 55-71, issn 0049-3848Article

Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene graftsHEYLIGERS, Jan M. M; VERHAGEN, Hence J. M; ROTMANS, Joris I et al.Journal of vascular surgery. 2006, Vol 43, Num 3, pp 587-591, issn 0741-5214, 5 p.Article

Le surdosage à l'héparine = Heparin overdoseNGUYEN, Philippe.STV. Sang thrombose vaisseaux. 2004, Vol 16, Num 5, pp 263-267, issn 0999-7385, 5 p.Article

Histoire des anticoagulants : l'héparine = Anticoagulant historyREGNIER, Christian.Archives des maladies du coeur et des vaisseaux. Pratique. 2001, Num 96, issn 1261-694X, p. 38Article

Surface tension effects of heparin coating on arterial line filtersPALANZO, D. A; KURUSZ, M; BUTLER, B. D et al.Perfusion. 1990, Vol 5, Num 4, pp 277-284, issn 0267-6591Article

Beneficial effect of heparin in the management of patients with APLHOYLE, C. F; SWIRSKY, D. M; FREEDMAN, L et al.British journal of haematology. 1988, Vol 68, Num 3, pp 283-289, issn 0007-1048Article

Konformationsanalyse. XXVIII: Konformationsanalyse von Heparin-analogen Di- and Trisacchariden mit α-L-Idopyranose-Einheiten = Analyse conformationnelle. XXVIII. Analyse de la conformation de dioxides et triosides contenus dans l'héparine avec des unités αL-idopyranose = Conformation analysis. XXVIII: Conformation analysis heparin di- and trisaccharides with α-L-Idopyranose containing unitsPAULSEN, H; POLLEX, A; SINNWELL, V et al.Liebigs Annalen der Chemie. 1988, Vol 1988, Num 5, pp 411-418, issn 0170-2041Article

Heparin-like anticoagulants in asthmaLASSER, E. C; SIMON, R. A; LYON, S. G et al.Allergy (Copenhagen). 1987, Vol 42, Num 8, pp 619-625, issn 0105-4538Article

Augmentation de la fréquence des thrombopénies à l'héparine, résultat d'un meilleur dépistage = Increased frequency of heparin-induced thrombocytopenia, effect of a better surveyLAINE-CESSAC, P; LEQUAY, L; FRESSINAUD, E et al.Thérapie (Paris). 1987, Vol 42, Num 4, pp 411-412, issn 0040-5957Article

Efficiency of polymer beads in the removal of heparin : Toward the development of a novel reactorSUNIL VARGHESE, M; HILDEBRANDT, D; GLASSER, D et al.Artificial cells, blood substitutes, and biotechnology. 2006, Vol 34, Num 4, pp 419-432, 14 p.Article

Selectively O-acylated glycosaminoglycan derivativesPETITOU, M; COUDERT, C; LEVEL, M et al.Carbohydrate research. 1992, Vol 236, pp 107-119, issn 0008-6215Article

Characterization of platelet binding of heparins and other glycosaminoglycansSOBEL, M; ADELMAN, B.Thrombosis research. 1988, Vol 50, Num 6, pp 815-826, issn 0049-3848Article

Application of multiple-quantum filters in zero-quantum spectroscopyFARMER, B. T. II; RAMACHANDRAN, R; BROWN, L. R et al.Journal of magnetic resonance. 1987, Vol 73, Num 3, pp 534-538, issn 0022-2364Article

Les héparines de bas poids moléculaire/Réunion du Groupe d'Etudes sur l'Hémostase et la Thrombose de la Société Française d'Hématologie, Nancy, 21-22 novembre 1987 = Heparins of low molecular weight/meeting of «groupe d'Etudes sur l'hémostase et la thrombose de la Société Française d'Hématologie», Nancy, 21-22 November 1987ALEXANDRE, P; SAMAMA, M.Journal des maladies vasculaires. 1987, Vol 12, pp 55-151, issn 0398-0499, suppl. BConference Proceedings

Heparin Concentration―Based Anticoagulation for Cardiac Surgery Fails to Reliably Predict Heparin Bolus Dose RequirementsGARVIN, Sean; FITZGERALD, Daniel C; DESPOTIS, George et al.Anesthesia and analgesia. 2010, Vol 111, Num 4, pp 849-855, issn 0003-2999, 7 p.Article

Quels contrôles sur les héparines ? = Which control on the heparins ?BROWAEYS, Dorothée Benoit.Recherche (Paris, 1970). 2004, Num 379, pp 60-63, issn 0029-5671, 4 p.Article